Stratec SE
0RAR.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$285.66M
Close$
$11.04
53% downside
Current Fair Value
53% downsideOvervalued by 53% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $285.66 Million |
|---|---|
| Enterprise Value | $384.90 Million |
| Dividend Yield | $0.60 (2.62%) |
| Earnings per Share | $-0.02 |
| Beta | 0.8 |
| Outstanding Shares | 12,155,942 |
Return
| Return on Equity | -0.17% |
|---|---|
| Return on Assets | -0.10% |
| Return on Invested Capital | 1.89% |
Valuation & Multiples
| P/E Ratio | -572.5 |
|---|---|
| PEG | -260.34 |
| Price to Sales | 1.18 |
| Price to Book Ratio | 1.24 |
| Enterprise Value to Revenue | 1.57 |
| Enterprise Value to EBIT | 55.98 |
| Enterprise Value to Net Income | -975 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 0.5 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$0.19
Average shareholder expectationRevenue Estimate
$58.80 M
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$0.23
Average shareholder expectationRevenue Estimate
$59.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Stratec SE
1,403 employees
CEO: Marcus Wolfinger Stratec SE, a company established in 1979 and headquartered in Birkenfeld, Germany (which operated as STRATEC Biomedical AG until December 2018), specializes in the development and production of advanced automation and instrumentation so...